Oncogenic B-Myb Is Associated With Deregulation of the DREAM-Mediated Cell Cycle Gene Expression Program in High Grade Serous Ovarian Carcinoma Clinical Tumor Samples
Cell cycle control drives cancer progression and treatment response in high grade serous ovarian carcinoma (HGSOC). MYBL2 (encoding B-Myb), an oncogene with prognostic significance in several cancers, is highly expressed in most HGSOC cases; however, the clinical significance of B-Myb in this diseas...
Main Authors: | Audra N. Iness, Lisa Rubinsak, Steven J. Meas, Jessica Chaoul, Sadia Sayeed, Raghavendra Pillappa, Sarah M. Temkin, Mikhail G. Dozmorov, Larisa Litovchick |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.637193/full |
Similar Items
-
MuvB: A Key to Cell Cycle Control in Ovarian Cancer
by: Audra N. Iness, et al.
Published: (2018-06-01) -
Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma
by: Xue Zhang, et al.
Published: (2017-08-01) -
Mechanisms of B-Myb oncogenicity in ovarian cancer
by: Iness, Audra N
Published: (2018) -
MYB Proto-oncogene-like 1-TWIST1 Axis Promotes Growth and Metastasis of Hepatocellular Carcinoma Cells
by: Binhui Xie, et al.
Published: (2020-09-01) -
Analysis of Bulk RNA Sequencing Data Reveals Novel Transcription Factors Associated With Immune Infiltration Among Multiple Cancers
by: Lei Liu, et al.
Published: (2021-08-01)